An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells

James Davies1, Andres F Vallejo1, Sofia Sirvent1

  • 1Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.

Summary

Researchers identified IRF1 as a key transcription factor controlling immune activation in Langerhans cells (LCs). Mathematical modeling revealed how LCs switch between immune tolerance and immunogenicity based on microenvironmental signals.